RADx-Underserved Populations (RADx-UP) has improved access to and acceptance of COVID-19 testing for underserved populations. The goal is to make millions of tests available to Americans each week, especially those most vulnerable to and disproportionately affected by COVID-19. 

NIH has partnered with other government organizations including the Biomedical Advanced Research and Development Authority (BARDA), the Centers for Disease Control and Prevention (CDC), the Defense Advanced Research Projects Agency (DARPA), the Health Resources and Services Administration (HRSA), and the U.S. Food and Drug Administration (FDA) to help achieve this goal.  

The RADx-UP program includes four associated funding opportunity announcements. Read more about this initiative here.

Source: ninr.nih.gov/newsandinformation/newsandnotes/radxupblog